![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Biocorp Earns CE Mark for Insulin Tracker
Biocorp Earns CE Mark for Insulin Tracker
Biocorp has gained approval in Europe for the Mallya smart sensor, a device that records key treatment information for diabetic patients.
The sensor connects conventional insulin pens to a mobile app, tracking the selected dose, date and time of injection. The automated recording eliminates the need for logbooks and manual recordkeeping.
The device also creates a summary report of a patient’s injected doses over the previous three months.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct